Q4 2020 13F Holders as of 12/31/2020
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
20
-
Total 13F shares, excl. options
-
3.26M
-
Shares change
-
+1.15M
-
Total reported value, excl. options
-
$5.08M
-
Value change
-
+$1.89M
-
Put/Call ratio
-
1.4
-
Number of buys
-
11
-
Number of sells
-
-7
-
Price
-
$1.56
Significant Holders of IGC Pharma, Inc. - COM NEW (IGC) as of Q4 2020
31 filings reported holding IGC - IGC Pharma, Inc. - COM NEW as of Q4 2020.
IGC Pharma, Inc. - COM NEW (IGC) has 20 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3.26M shares
.
Largest 10 shareholders include BlackRock Inc. (909K shares), VANGUARD GROUP INC (714K shares), Carroll Financial Associates, Inc. (445K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (272K shares), GEODE CAPITAL MANAGEMENT, LLC (262K shares), BRIDGEWAY CAPITAL MANAGEMENT, LLC (192K shares), DEARBORN PARTNERS LLC (96.9K shares), GOLDMAN SACHS GROUP INC (83.3K shares), NORTHERN TRUST CORP (63K shares), and TRUIST FINANCIAL CORP (36.7K shares).
This table shows the top 20 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.